Riskpilot← Back to searchSign inGet full accessWellth AB
ABActiveOrg 5591119036Kosmosvägen 12General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 1,2M
+66% vs 2023
EBITDA margin
4.4%
+207% vs 2023
Equity ratio
39.7%
Financial strength
Net profit 2024
SEK 51K
+207% vs 2023
| Revenue | SEK 1,2M | +66% |
| EBITDA | SEK 51K | +207% |
| Net profit | SEK 51K | +207% |
| Total assets | SEK 197K | +52% |
| Equity | SEK 78K | +188% |
| Employees | 0 | — |
Legal name
Wellth AB
Org number
5591119036
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska vara verksamt inom näringsmedicin och hälsa, inkluderande blod, urin och andra typer av hälsotest, analys av blodprov och resultat, professionella näringstjänster och därmed förenlig verksamhet. Förvaltning av fast och lös egendom samt därmed förenlig verksamhet.
Address
Kosmosvägen 12
Email
jackie@nordicwellth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 692 | 699 | 723 | 694 | 1 153 |
| Staff expenses | — | — | −7 | −0 | — |
| EBITDA | −16 | 10 | −107 | −48 | 51 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −16 | 10 | −107 | −48 | 51 |
| Net financials | — | — | −0 | −0 | −0 |
| Profit before tax | −13 | 10 | −107 | −48 | 51 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −13 | 10 | −107 | −48 | 51 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 218 | 224 | 111 | 129 | 197 |
| Equity | 38 | 48 | 25 | 27 | 78 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 180 | 176 | 85 | 102 | 119 |
| Total debt | 180 | 176 | 85 | 102 | 119 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
39.7%
This company
38.2%
Market median
+4% vs market
20202024
Return on equity
65.3%
This company
18.4%
Market median
+255% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
5.85×
This company
1.12×
Market median
+422% vs market
20202024
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wellth AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacqueline Jackie Louise Cawthra | Board of Directors | 0 companies |
| Tord Magnus Eriksson | Deputy Board Member | 0 companies |
| Maria Eleonora Berglund Rantén | Chairman | 0 companies |
| Mikael Arne Berglund | Deputy Board Member | 0 companies |